Analyst Ratings for Adaptimmune Therapeutics plc (ADAP) [Neutrals]
ADAP Rating Summary
ADAP Price Target Summary
- Highest: $9.00 (Mizuho)
- Lowest: $2.00 (Wells Fargo)
- Average: $4.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$4.67 (+376.2%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 72%
Avg. $ Target:
$4.67 (+376.2%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 72%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/7/2019 | Leerink Partners » Updated 6/1/2020 |
Jonathan Chang | Downgrade | Market Perform (Outperform) |
11.00 (4.00) |
4.64 (0.98) |
-78.88% | Details |
| 3/17/2017 | Wells Fargo » Updated 11/9/2023 |
N/A | New Coverage | Equal Weight (N/A) |
2.00 (3.00) |
4.75 (0.98) |
-79.37% | Details |
